Abbott Laboratories · NYSE:ABT

Blount Sally E. received 2,286 Abbott Laboratories shares as an award (Form 4)

Traded Apr 24, 2026 · Filed Apr 28, 2026

On Apr 24, 2026, Blount Sally E. (Director) received 2,286 Abbott Laboratories shares as an award, leaving 36,344 shares. Filed Apr 28, 2026 (Form 4).

Awarded
2,286 shares
Holding after
36,344 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 24, 2026Common shares without par valueAward2,28636,344Direct

Source

View original at SEC

Related